Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/2000
01/19/2000EP0971662A1 Fatty acid esters of glycolic acid and its salts as permeation enhancers
01/19/2000EP0971641A1 Intravesical drug delivery system
01/19/2000EP0971589A1 Process and means for the eradication of ticks in the habitats of small mammals
01/19/2000EP0971588A1 Novel cannabinoid receptor modulators
01/19/2000EP0971587A1 Quinoline leukotriene antagonists
01/19/2000EP0971585A1 Method of inhibiting cancer growth
01/19/2000EP0859751B1 Semi-fluorinated alkanes and their use
01/19/2000EP0847240A4 Novel embolizing compositions
01/19/2000EP0809623B1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
01/19/2000EP0746322B1 Treatment of alzheimer's disease with delta5-androstenes
01/19/2000EP0726899B1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments
01/19/2000EP0723546B1 1,2,4 - TRIZOLO[1,5-a]PYRIMIDINE AND THEIR USE FOR TREATMENT OF NEUROLOGICAL DISORDERS
01/19/2000EP0701440B1 Tri(platinum) complexes
01/19/2000EP0696917B1 Method for inhibiting posterior capsule opacification
01/19/2000EP0617962B1 Obesity inhibitor
01/19/2000EP0601164B1 Methods for treating viral infections
01/19/2000CN1242045A Immunotherapy and improved vaccines
01/19/2000CN1242017A Meiosis regulating compounds
01/19/2000CN1242015A 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
01/19/2000CN1242014A Novel heterocyclic amide compounds and medicinal uses thereof
01/19/2000CN1242012A N-(pyridinylamino) isoindolines for treating alzheimer's and depression
01/19/2000CN1242007A Cycloalkyl, lactam lactone and related compounds as 'beta'-amyloid peptide release inhibitors
01/19/2000CN1242006A Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
01/19/2000CN1242005A Process for producing imidazole derivatives
01/19/2000CN1242001A Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
01/19/2000CN1242000A Farnesyl transferase inhibitors
01/19/2000CN1241999A Vitamin D3 derivatives
01/19/2000CN1241998A Synthesis of benzo (F) quinolinones
01/19/2000CN1241997A Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
01/19/2000CN1241943A New use of aminopiperazine derivatives
01/19/2000CN1241942A N-linked ureas and carbamates of heterocyclic thioesters
01/19/2000CN1241941A Treatment of neurodegenerative conditions with nimesulide
01/19/2000CN1241912A A method to prepare food seasoning, food ingredient and food item compositions, seasoning and use thereof
01/19/2000CN1241908A Endoparasiticidal and ectoparasiticidal agents
01/19/2000CN1241571A Low-toxicity antiphlogistic exudation-resisting medicine composition
01/19/2000CN1241558A Bicyclic aromatic compound and its application in human medicines or animal medicines and cosmetics teconology
01/19/2000CN1241429A Medicine for preventing chronic lead poisoning
01/19/2000CN1241405A Oral linmerjing as one kind of powerful anti-bacterial medicine
01/19/2000CN1241404A Avermectin-or ivermectin-containing slow releasing injecta
01/19/2000CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition
01/19/2000CN1048495C Tetrahydropyran derivatives, its producing process and their medical composition containing them
01/19/2000CN1048494C Process for preparing carbapenen and penem compounds and new compound involved in that process
01/19/2000CN1048493C O6-substituted guanine derivatives, a process for their prepn. and their use
01/19/2000CN1048492C Quinuclidine derivatives and its preparation
01/19/2000CN1048490C Cyclic derivatives, pharmacecctical compositions containg the same derivatives and their use
01/19/2000CN1048489C Novel anti-virus compound methyl brevifolin carboxylic ester and method for prepn. of same
01/19/2000CN1048488C Novel compound for anti-virus and method for prepn. of same
01/19/2000CN1048486C Method for preparing benzimidazole derivatives
01/19/2000CN1048484C A process for preparing a composition containing benzoheterocycles
01/19/2000CN1048400C Vitamin micro-element purine pyrimidine dinucleotide nutrient product and producing process
01/19/2000CN1048399C Levomisol liniment
01/19/2000CN1048396C Granular preparation
01/19/2000CN1048394C Chlordimethasone aerosol
01/19/2000CN1048384C Growth promoting composition for fish and its using method
01/18/2000US6015926 Adding dialkylzinc to chiral additive, adding second additive to form chiral zinc complex, mixing with organometallic reagent, reacting with carbonyl compound to form desired alcohol
01/18/2000US6015913 Heating cocoa beans to loosen shell without roasting nib, winnowing nibs from shells, screw pressing nibs to produce cocoa butter and partially defatted cocoa solids
01/18/2000US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease
01/18/2000US6015904 Stable reagents for the preparation of radio pharmaceuticals
01/18/2000US6015901 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
01/18/2000US6015900 N-aminoalkylfluorenecarboxamides
01/18/2000US6015894 Oligonucleotide modulation of cell adhesion
01/18/2000US6015893 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis
01/18/2000US6015892 Nucleotide sequences for diagnosis and treatment of related disorders; antisense/anticarcinogenic/antitumor agents; antiinflammatory/antiproliferative agents
01/18/2000US6015883 Amino acid sequence of purified chemokine polypeptide; treatment of immune deficiency diseases, autoimmune diseases, allergies or asthma; anticarcinogenic/antiinflammatory/ antiarthritic agents
01/18/2000US6015879 Compounds for treatment of nervous system disorders including alzheimer's disease, cognition defects, down's syndrome, parkinson's disease, cerebral hemorrhage with amyloidosis, dementia pugilistica, and head trauma
01/18/2000US6015837 Method for treating scoliosis with β2-adrenoceptor agonists
01/18/2000US6015835 Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
01/18/2000US6015834 Administering chelate compound; antiischemic, antiepileptic, and wound healing agents; treating brain and nervous system disorders
01/18/2000US6015833 Conjugated linoleic acid compositions
01/18/2000US6015832 Methods of inactivating bacteria including bacterial spores
01/18/2000US6015831 Thiophene nitrone compounds
01/18/2000US6015827 Benzoxazole-4-carboxamides and their use in inhibiting poly (adp-ribose) polymerase activity and improving cytotoxic effectiveness of cytotoxic drugs or radiotherapy
01/18/2000US6015825 Triazole antifungal agents
01/18/2000US6015824 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders
01/18/2000US6015822 Antiulcer, antidiarrhea, and antiarrhythmia agents; cardiovascular and gastrointestinal disorders
01/18/2000US6015821 Skin, psychological and cardiovascular disorders; anticarcinogenic, antiinflammatory and antidiabetic agents
01/18/2000US6015820 4-Aryl-thio-pyridin-2(1H)-ones, medicines containing them and their uses in the treatment of illnesses linked to HIV
01/18/2000US6015819 Administering adrenergic blocking agent; reduction of orthostatic fall in blood pressure side effect; fda orange book listed patent for silodosin
01/18/2000US6015818 Quinoline derivatives as bradykinin agonists
01/18/2000US6015816 Attaching an antimicrobial ligand to clay in excess of the cationic exchange capacity, thereby imparting increased antimicrobial activity,controlling microbial growth on a material
01/18/2000US6015814 Quinazoline derivative
01/18/2000US6015812 N-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity
01/18/2000US6015811 Antitumor Chrysene derivatives
01/18/2000US6015810 Aqueous ophthalmic solution containing apafant as active ingredient
01/18/2000US6015807 Protein kinase C inhibitor
01/18/2000US6015806 Topical use in the treatment of androgen-dependent diseases associated with the skin.
01/18/2000US6015805 Potent antiprogestational activity and are useful in the treatment of fibroids, endometriosis, cervical ripening prior to delivery, hormone replacement therapy and in the control of fertility.
01/18/2000US6015804 Method of using tetracycline compounds to enhance interleukin-10 production
01/18/2000US6015803 Antibiotic treatment of age-related macular degeneration
01/18/2000US6015801 Histamine h2 receptor blocker or a proton pump inhibitor and a unit dosage of a bisphosphonate, i.e. alendronate.
01/18/2000US6015799 Restricting the degree of substitution of the dextrin sulphate to a maximum of 2,
01/18/2000US6015798 Mixture of omega-3 polyunsaturated fatty acids and arginine, cats and dogs
01/18/2000US6015797 Adenosinergic agonist containing pharmaceutical composition with analgesic activity
01/18/2000US6015796 Polysaccharide derived from a hot water extract of human-type tubercle bacillus and (b) a nucleoside-type anti-hiv agent.
01/18/2000US6015793 Use of tagatose to enhance key blood factors
01/18/2000US6015712 Antisense modulation of FADD expression
01/18/2000US6015669 Identification of genes
01/18/2000US6015659 Inducement of thermotolerance with benzoquinonoid ansamycins
01/18/2000US6015578 Trapidil for use in the therapy of syndrome that may be influenced by immunomodulators
01/18/2000US6015577 Treatment of strokes